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ABSTRACT; 
Background; The annual incidence of tuberculous meningitis (TM) is unknown. TM is a disease that still often 
results in residual sequelae, and has a mortality rate ranging between 15 and 51%. Experience of countries such 
as Pakistan where drug-resistant tuberculosis and TM are prevalent is important. Objective:  To determine the 
frequency of M. Tuberculosis detection in CSF of patients with suspected tuberculous meningitis. Materials and 
Methods; The study was conducted at the Inpatient department of Medicine, Nishtar Hospital Multan. The 
demographic data like age, sex, height, weight, monthly family income and address of the patients was collected. 
Cases of TBM fulfilling inclusion and exclusion criteria were included in the study. CSF was collected after 
consent, through lumbar puncture (LP) done by the post graduate trainee (author or colleagues) under aseptic 
measures and was sent to the designated hospital laboratory for GeneXpert MTB/Rif assay and report was 
assessed for M. tuberculosis detection. Data was collected and entered in SPSS and analyzed. 
Results; total of 95 patients with tuberculous meningitis meeting inclusion criteria of our study were included in 
this study. Of these 95 study cases, 37 (38.9%) were male patients while 58 (61.1%) were female patients. Mean 
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age of our study cases was 26.62 ± 5.94 years. Of these 95 study cases, 49 (51.6%) were from rural areas and 46 
(48.4%) belonged to the urban areas while 62 (65.3%) were from poor families. Seventeen (17.9%) had diabetes 
and 25 (26.3%) were having history of hypertension. Mean weight of our study cases was 56.16 ± 10.27 
kilograms and 66 (69.5%) had up to 60 kilograms of weight. Mycobacterium tuberculous was noted in 49 
(51.6%) of our study cases  
Conclusion; High frequency of Mycobacterium tuberculosis was observed in our study in cerebrospinal fluid 
(CSF) of suspected patients of tuberculosis meningitis using genexpert MTB/RIF assay. Mycobacterium 
tuberculosis was significantly associated with age, socioeconomic status, diabetes and hypertension.  
Keywords; Tuberculous meningitis, Mycobacterium TB, Genexpert.  
 
INTRODUCTION: 
 Tuberculosis (TB) is a devastating illness caused by infection with Mycobacterium tuberculosis (MTB) 
and may involve any system of the body. It is estimated that about 1/3
rd
 of the world’s population is infected 
with tuberculosis (latent)
 1
. In 2014, an estimated 4 million new cases of TB appeared in South East Asia (SEA) 
WHO region which is about 41% of the estimated global TB cases
2
. While in Pakistan, figures for new TB cases 
reached 3,08,417 in 2014
3
. About 10% of patients who have tuberculosis develop tuberculous meningitis (TBM) 
4
, a severe and life threatening central nervous system (CNS) involvement. Approximately a third of patients 
with TBM die soon after presenting to the hospital and many of those surviving are left with severe neurological 
sequel
5
. Prompt diagnosis and treatment of TBM have been shown to be the best predictor of survival
6
. 
However, conventional confirmatory test available for TBM i.e. culture & sensitivity of cerebrospinal fluid 
(CSF) takes 1 to 4 weeks to return a positive test and time is one thing which a patient with TBM is very short 
of. Therefore the clinical value of culture technique is limited to diagnostic confirmation, drug susceptibility 
testing and molecular typing of Mycobacterium tuberculosis. Another most widely applied rapid diagnostic 
technique; Zeihl-Neelson (ZN) microscopic staining of CSF for acid fast bacilli (AFB) has a sensitivity rarely 
exceeding 20% for TBM
7
. With recent advances, more techniques have been evolved e.g. adenosine deaminase 
assay (ADA), nucleic acid amplification techniques(NAAT), Multiplex PCR, GeneXpert MTB/RIF etc., each of 
which has its own pros and cons
8
. Out of these GeneXpert has gained wide popularity. 
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 The GeneXpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) is the only fully automated closed-
cartridge real time DNA-based system that is easy to be operated by minimally trained staff and can detect TB in 
less than 2 hours and carries a smaller risk for biohazard and cross-contamination
9
. The Xpert MTB/RIF test was 
approved by the World Health Organization (WHO) in 2010 for the diagnosis of pulmonary TB following 
extensive evaluation projects in six countries led by the Foundation for Innovative New Diagnostics (FIND) 
10
. 
The test has shown sensitivity above 90% for culture positive tuberculosis with high specificity in sputum 
samples, however Xpert MTB/RIF has also been used successfully for extra pulmonary samples including 
cerebrospinal fluid (CSF) 11. Since the introduction of the technology, cost per test has significantly dropped11 
and recently it is comparable to or even less than the conventional TB confirmatory test  i.e. MTB culture & 
sensitivity. Availability has also increased rapidly in recent years. Currently 42 sites in Pakistan are offering 
GeneXpert
3
. To further betterment, under a project - known as TBXpert - by UNITAID, not only cartridge prices 
were dropped  40% leading to USD 9.98 per cartridge12 in 145 countries but also 220 test machines and over a 
million cartridges were purchased in 2013 and with the co-ordination of WHO, installed free of any cost at 
various places in 21 countries of the developing world13 including Pakistan.  
As with the clinical practice, TBM cases in research are selected according to some clinical criteria 
known as composite reference standard (CRS) which in previous studies used to be author defined, causing 
diversity in definition and thus proving to be a major stumbling block in comparing various research findings 
and data. To address this problem, in 2010 at South Africa a committee was appointed by 41 international 
experts in research of TBM, to finalize a consensus criteria for tuberculous meningitis for use in future clinical 
research; i.e. Uniform Tuberculous Meningitis Research Case Definition14. This is kind of a scoring system (total 
score = 20) which distributes selected patients into three categories i.e. definite, probable and possible; where 
'definite' being the ones with positive CSF M. tuberculosis culture or positive NAAT or AFB on smear 
microscopy in context of typical clinical findings and other two categories making up the suspected cases. Since 
the theme of this study is to use GeneXpert in place of other diagnostic tools and this that the use of assay in 
already confirmed cases of TBM can be a burden on resources and it is not a comparative study, segregation of 
certain number of patients into 'definite' category seems to reduce the yield of the study. Therefore confirmatory 
tests e.g. culture will not be included in this study and all the selected cases was termed 'suspected' only (score ≥ 
6), irrespective of any category.  When same approach was followed in part of a study at Vietnam in 2013 under 
the Oxford University Clinical Research Unit, researchers found 59.3% positive results in all the suspected 
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cases
15
 (all categories combined) which were no more different than true positive results. According to a meta-
analysis of 6 global studies, in an Expert group meeting report 2013 by WHO, pooled sensitivity of the assay in 
CSF was 55.5% when compared against composite reference standard (CRS) 
11
. The WHO Expert group 
recommends that Xpert MTB/RIF should be used in preference to conventional microscopy and culture as the 
initial diagnostic test when testing CSF from patients suspected of having TBM
11
. 
 Due to the urgency of diagnosis in suspected TBM cases, a rapid diagnostic test like Genexpert will 
have a great impact on survival. One published study in Pakistan in 2015, on Xpert MTB/RIF assay, included 
only one sample of CSF16. Aim of this study was to determine frequency of Mycobacterium tuberculosis 
detection using GeneXpert MTB/RIF assay, in CSF of patients suspected to be suffering from TBM.  
 
Materials and Methods 
Patients fulfilling the diagnostic criteria in the Uniform Tuberculous Meningitis Research Case Definition (Score 
≥ 6), aged 15 to 50 years of either sex were enrolled in this study. Patients already on treatment for TBM, 
Patients with recurrent Tuberculous Meningitis, having contraindications to lumbar puncture i.e. local infection, 
bleeding tendencies, papilledema and patients with known immunodeficiency states i.e. HIV (evidenced on 
screening test) or chemotherapy, radiotherapy or immunosuppressant drugs were excluded from our study. The 
patients were enrolled from the Inpatient department of Medicine, Nishtar Hospital Multan. The demographic 
data like age, sex, height, weight, monthly family income and address of the patients was collected. Cases of 
TBM fulfilling inclusion and exclusion criteria were included in the study. CSF was collected after consent, 
through lumbar puncture (LP) done by the post graduate trainee (author or colleagues) under aseptic measures 
and was sent to the designated hospital laboratory for GeneXpert MTB/Rif assay and report will assessed for M. 
tuberculosis detection. Data was entered using software SPSS version 20.  
 
RESULTS; 
A total of 95 patients with tuberculous meningitis meeting inclusion criteria of our study were included 
in this study. Of these 95 study cases, 37 (38.9%) were male patients while 58 (61.1%) were female patients. 
Mean age of our study cases was 26.62 ± 5.94 years (with minimum age was 19 years while maximum age of 
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our study cases was 41 years). Mean of the male patients was 27.35 ± 6.34 years while mean age of the female 
patients was 26.16 ± 5.68 years (p=0.342). Our study results have indicated that majority of our study cases i.e. 
78 (82.1%) were aged up to 30 years. Of these 95 study cases, 49 (51.6%) were from rural areas and 46 (48.4%) 
belonged to the urban areas. Mean monthly family income was 21455.78 ± 5443.23 rupees and 62 (65.3%) were 
from poor families. Seventeen (17.9%) had diabetes and 25 (26.3%) were having history of hypertension. Mean 
weight of our study cases was 56.16 ± 10.27 kilograms and 66 (69.5%) had up to 60 kilograms of weight. 
Mycobacterium tuberculous was noted in 49 (51.6%) of our study cases. 
 
DISCUSSION; 
Meningitis is the inflammation of meninges that results in many signs and symptoms. A wide variety of causes 
include infectious and noninfectious are important. PCR as a diagnostic test for TBM has a sensitivity of 50% 
and a specificity close to 100%. Use of real-time PCR for TB results in early diagnosis and treatment, therefore, 
results in decreasing mortality and morbidity. A total of 95 patients with tuberculous meningitis meeting 
inclusion criteria of our study were included in this study. Of these 95 study cases, 37 (38.9%) were male 
patients while 58 (61.1%) were female patients. A study conducted by Nabi et al 
17 
from Islamabad reported 55 
% female gender preponderance which is in compliance with our study results. A study conducted by Saleem et 
al from Lahore 
 18 
also reported 52 % female gender predominance which is in compliance with our study results. 
A study conducted in Turkey by Yasar et al 
 19 
reported equal distribution of male and female patients. A study 
conducted by Sher et al 
 20 
from Karachi has also reported 57 % female gender predominance which is close to 
our study results.  
Mean age of our study cases was 26.62 ± 5.94 years (with minimum age was 19 years while maximum 
age of our study cases was 41 years). Mean of the male patients was 27.35 ± 6.34 years while mean age of the 
female patients was 26.16 ± 5.68 years (p=0.342). Our study results have indicated that majority of our study 
cases i.e. 78 (82.1%) were aged up to 30 years. A study conducted by Nabi et al 
17 
from Islamabad reported 
34.86± 17.54 years mean age of the patients with tuberculous meningitis which is close to our study results. A 
study conducted by Saleem et al 
 18 
from Lahore also reported mean age for male patients were 34±17 years and 
for female patients it was 29.81±17.72 years (p-value=0.398) which is in compliance with that of our study 
results. Fazel et al 
 21  
from Karachi reported 29.65 years mean age of the patients with tuberculous meningitis 
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which is close to our study results. A study conducted by Saleem et al from Lahore 
 102 
also reported 34 ± 17 
years mean age which is similar to our study results. A study conducted in Turkey by Yasar et al  19 reported 
32.18 ± 13.62 years mean age of the patients with tuberculous meningitis which is close to our study results.  
Of these 95 study cases, 49 (51.6%) were from rural areas and 46 (48.4%) belonged to the urban areas. 
Mean monthly family income was 21455.78 ± 5443.23 rupees and 62 (65.3%) were from poor families. 
Seventeen (17.9%) had diabetes and 25 (26.3%) were having history of hypertension. A study conducted by 
Shore et al 
 103 
from Lahore reported 22 % diabetes which is close to our study results.  
Mycobacterium tuberculous was noted in 49 (51.6%) of our study cases. a study at Vietnam in 2013 
under the Oxford University Clinical Research Unit, researchers found 59.3% positive results in all the suspected 
cases15 which is in compliance with our study results. According to a meta-analysis of 6 global studies, in an 
Expert group meeting report 2013 by WHO, pooled sensitivity of the assay in CSF was 55.5% 
11
 which is close 
to our study results. Similar results have been reported by an Indian study conducted by Anuradha et al 24.  
 
CONCLUSION; 
High frequency of Mycobacterium tuberculosis was observed in our study in cerebrospinal fluid (CSF) 
of suspected patients of tuberculosis meningitis using genexpert MTB/RIF assay. Mycobacterium tuberculosis 
was significantly associated with age, socioeconomic status, diabetes and hypertension.  
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